Amgen
AMGN
$241.03
Share price
1.07%
Change (1 day)
-0.21%
Change (1 year)
Categories
The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.
Amgen (AMGN) Fails to deliver data
Key failure to deliver metrics for Amgen:
- Last SEC data release: 2023-02-28
- Last 15 days FTD volume: $0.02 M
- Last 3 months FTD volume: $81.07 M
- Last year FTD volume: $0.51 B
Failures to deliver for Amgen (AMGN) - 3 month history
Number of shares, 3 month chartBiweekly Failures to deliver volume for Amgen (AMGN) - since 2013
Volume in USD (price x number of shares), data since 2013Amgen (AMGN) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2023 | $64.15 M | -87.47% |
| 2022 | $0.51 B | 157.37% |
| 2021 | $0.19 B | 22.68% |
| 2020 | $0.16 B | 98.48% |
| 2019 | $81.68 M | -82.11% |
| 2018 | $0.45 B | 188.65% |
| 2017 | $0.15 B | -34.3% |
| 2016 | $0.24 B | -7.34% |
| 2015 | $0.25 B | 105.33% |
| 2014 | $0.12 B | 171.37% |
| 2013 | $46.63 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $66.53 M | $0.31 B | 🇺🇸 USA |
 Pfizer PFE | $0.23 B | $0.56 B | 🇺🇸 USA |
 AbbVie ABBV | $0.13 B | $0.43 B | 🇺🇸 USA |
 Eli Lilly LLY | $42.87 M | $0.29 B | 🇺🇸 USA |
 Biogen BIIB | $8.79 M | $65.55 M | 🇺🇸 USA |
 Gilead Sciences GILD | $33.96 M | $0.28 B | 🇺🇸 USA |
 Illumina ILMN | $3.47 M | $50.24 M | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $63.47 M | $0.22 B | 🇺🇸 USA |
 GlaxoSmithKline GSK | $27.64 M | $72.38 M | 🇬🇧 UK |